The bottom line—for me, anyway—is to find out how much a universal pharmacare program would cost and how much and where the savings would be from such things as streamlined administration, bulk buying, cost-related nonadherence, etc. Those are the two main things: what it would cost and where our savings would be.
That's the bottom line, I guess. Is that something the PBO could do?